The role of TRIM25 in the occurrence and development of cancers and inflammatory diseases.

Maryam Rahimi-Tesiye, Mona Zaersabet, Sajad Salehiyeh, Seyedeh Zahra Jafari

Journal: Biochimica et biophysica acta. Reviews on cancer 2023;1878(5):188954

PMID: 37437700

Abstract

The tripartite motif (TRIM) family proteins are a group of proteins involved in different signaling pathways. The changes in the expression regulation, function, and signaling of this protein family are associated with the occurrence and progression of a wide range of disorders. Given the importance of these proteins in pathogenesis, they can be considered as potential therapeutic targets for many diseases. TRIM25, as an E3-ubiquitin ligase, is involved in the development of various diseases and cellular mechanisms, including antiviral innate immunity and cell proliferation. The clinical studies conducted on restricting the function of this protein have reached promising results that can be further evaluated in the future. Here, we review the regulation of TRIM25 and its function in different diseases and signaling pathways, especially the retinoic acid-inducible gene-I (RIG-I) signaling which prompts many kinds of cancers and inflammatory disorders.

Copyright © 2023 Elsevier B.V. All rights reserved.

Address: Faculty of Life Science and Biotechnology, Shahid Beheshti University, Tehran, Iran.; Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran. Electronic address: [email protected].; Department of Physiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.; Student Research Committee, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.